ECD Automotive Design, Inc. (ECDA) Dividend History

ECD Automotive Design, Inc. (ECDA) specializes in customizing and building luxurious, high-end vehicles, including specialty SUVs and trucks. The company focuses on delivering bespoke automotive interior and exterior modifications, often in collaboration with premium brands, catering to clients seeking personalized and exclusive vehicle enhancements.

24 Shipyard Drive, Suite 102, Hingham, MA, 02043
Phone: 929-528-0767
Website: https://www.ecdautodesign.com

Dividend History

ECD Automotive Design, Inc. currently does not pay dividends

Company News

  • ECD Auto Design, a U.S. auto manufacturer, reported a 29% increase in revenues to $25 million for the full year 2024. The company saw growth in volume, average selling price, and used vehicle sales, but also incurred higher expenses related to being a public company and financial restatements.

    GlobeNewswire Inc.
  • ECD Automotive Design, Inc. (ECDA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

    Zacks Investment Research
  • Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24 insurance revenue guidance. Clover Health Investments reported quarterly sales of $510.3 million which beat the analyst consensus estimate of $480.25 million by 6.26% and represents a 43.22% decrease over sales of $898.79 million the same period last year. Clover Health Investments shares climbed 11.2% to $0.8537 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers Gaxos.ai Inc. (NASDAQ: GXAI) shares jumped 128.9% to $12.18 after the company announced it acquired the rights to use certain AI-enabled technology from Ultiself. Veritone, Inc. (NASDAQ: VERI) gained 52.4% to $2.6076 following strong sales results. NuCana plc (NASDAQ: NCNA) gained 50.2% to $0.5869 after the company was granted a US Patent for "Phosphoramidate Derivatives For Use In The Treatment Of Cancer; Especially In The Treatment Where The Patient Shows Resistance." The Beauty Health Company (NASDAQ: SKIN) rose 31.9% to $4.7350 after the company reported better-than-expected fourth-quarter revenue results. Arq, Inc. (NASDAQ: ARQ) gained 28.3% to $4.4522 after the company reported upbeat fourth-quarter results. MicroCloud Hologram Inc. (NASDAQ: HOLO) jumped 26.6% to $6.19. Kintara Therapeutics, Inc. (NASDAQ: KTRA) shares gained 26.2% to $0.1055. Nature's Sunshine Products, Inc. (NASDAQ: NATR) jumped 24.7% to $21.47 after the company reported better-than-expected fourth-quarter adjusted EPS results and issued FY24 net sales guidance. Heron Therapeutics, Inc. (NASDAQ: HRTX) gained 24.7% to $2.9428 after the company reported better-than-expected fourth-quarter adjusted EPS results and issued FY24 revenue guidance. Also, Needham maintained a Buy rating on the stock and raised its price target from $4 to $5. Li-Cycle Holdings Corp. (NASDAQ: LICY) shares gained 23.2% to $0.7233. Li-Cycle shares jumped 46% on Tuesday after the ...

    Benzinga
Page data last updated 07/23/2025 16:07:22 UTC